The UCLA Tuberous Sclerosis Complex (TSC) Program is one of the largest TSC programs in the Western United States. The program includes a multidisciplinary approach to clinical care for children with tuberous sclerosis complex, a newly developed adult TSC neurology clinic, and many clinical research studies and clinical trials to advance knowledge and improve care for this rare genetic condition.
Our clinic is a Tuberous Sclerosis Alliance-designated clinic. The clinic focuses on diagnostic and ongoing assessments including medical therapies, surgical treatments, and ketogenic diet evaluation and therapy.
Our research projects specifically focus on:
- Identifying biomarkers for the development of epilepsy
- Identifying biomarkers for the development of autism
- Improving epilepsy surgery outcomes for tuberous sclerosis complex
- Clinical trials for TSC-related epilepsy and tumors.